Keith Fandrick
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Keith Fandrick
Keith Fandrick is recorded as COO at Quince Therapeutics, Inc. (QNCX). Quince Therapeutics, Inc. reported in an 8-K filed October 9, 2026 that Keith Fandrick was appointed Chief Operating Officer, effective October 8, 2026.
“Effective as of the Effective Date, Keith Fandrick was appointed as Chief Operating Officer of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-10-08–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Quince Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Brigette Roberts CEO, Board Member
- Christopher Lowe CEO, Board Member
- Dirk Thye, M.D. CEO, Board Member
- David A. Lamond Chairman
- Brendan Hannah CFO
- John Militello CFO, Chief Accounting Officer
- Chris Lowe COO
- Keith R. Fandrick COO
- Brigette Roberts, M.D. Board Member
- Catherine Bonuccelli Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.